Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+10.8M
-
Total reported value, excl. options
-
$332M
-
Value change
-
+$115M
-
Put/Call ratio
-
0.81
-
Number of buys
-
44
-
Number of sells
-
-27
-
Price
-
$10.34
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q3 2019
91 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q3 2019.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 79.2M outstanding shares and own 40.52% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (6.75M shares), RA CAPITAL MANAGEMENT, L.P. (4.57M shares), BOXER CAPITAL, LLC (3.9M shares), Bain Capital Life Sciences Investors, LLC (3.87M shares), EcoR1 Capital, LLC (3.34M shares), Artal Group S.A. (1.7M shares), BlackRock Inc. (1.69M shares), VANGUARD GROUP INC (852K shares), MILLENNIUM MANAGEMENT LLC (793K shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (492K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.